372 related articles for article (PubMed ID: 11426648)
1. Bcl-2 family proteins as targets for anticancer drug design.
Huang Z
Oncogene; 2000 Dec; 19(56):6627-31. PubMed ID: 11426648
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibitors of Bcl-2 function: modulators of apoptosis and promising anticancer agents.
Huang Z
Curr Opin Drug Discov Devel; 2000 Sep; 3(5):565-74. PubMed ID: 19649884
[TBL] [Abstract][Full Text] [Related]
3. [Progress in small-molecule inhibitors of Bcl-2 family proteins].
Tang Y; Zhang DY; Wu XM
Yao Xue Xue Bao; 2008 Jul; 43(7):669-77. PubMed ID: 18819468
[TBL] [Abstract][Full Text] [Related]
4. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
Kostanová-Poliaková D; Sabová L
Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
[TBL] [Abstract][Full Text] [Related]
5. Robust lanthanide-based assays for the detection of anti-apoptotic Bcl-2-family protein antagonists.
Rega MF; Reed JC; Pellecchia M
Bioorg Chem; 2007 Apr; 35(2):113-20. PubMed ID: 16996562
[TBL] [Abstract][Full Text] [Related]
6. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy.
Dharap SS; Chandna P; Wang Y; Khandare JJ; Qiu B; Stein S; Minko T
J Pharmacol Exp Ther; 2006 Mar; 316(3):992-8. PubMed ID: 16291730
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
Doshi JM; Tian D; Xing C
J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
[TBL] [Abstract][Full Text] [Related]
8. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
9. Effect of antineoplastic drugs on the expression of Bcl-2 and Bcl-xL genes in the feline T-cell leukemia cell line.
Sano J; Nagafuchi S; Yamazaki J; Oguma K; Kano R; Hasegawa A
Res Vet Sci; 2005 Dec; 79(3):197-201. PubMed ID: 15893350
[TBL] [Abstract][Full Text] [Related]
10. Peptides in apoptosis research.
Salgado J; García-Sáez AJ; Malet G; Mingarro I; Pérez-Payá E
J Pept Sci; 2002 Oct; 8(10):543-60. PubMed ID: 12450324
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis.
Rudner J; Elsaesser SJ; Müller AC; Belka C; Jendrossek V
Biochem Pharmacol; 2010 Jan; 79(1):10-20. PubMed ID: 19665451
[TBL] [Abstract][Full Text] [Related]
12. The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members.
Verdine GL; Walensky LD
Clin Cancer Res; 2007 Dec; 13(24):7264-70. PubMed ID: 18094406
[TBL] [Abstract][Full Text] [Related]
13. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
[TBL] [Abstract][Full Text] [Related]
14. Induction of Bad-mediated apoptosis by Sindbis virus infection: involvement of pro-survival members of the Bcl-2 family.
Moriishi K; Koura M; Matsuura Y
Virology; 2002 Jan; 292(2):258-71. PubMed ID: 11878929
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological profiling of the pro-survival protein Bcl-xL.
Goreshnik I; Brock AM; Maly DJ
Bioorg Med Chem Lett; 2011 Sep; 21(17):4951-5. PubMed ID: 21807512
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
Shiau CW; Yang CC; Kulp SK; Chen KF; Chen CS; Huang JW; Chen CS
Cancer Res; 2005 Feb; 65(4):1561-9. PubMed ID: 15735046
[TBL] [Abstract][Full Text] [Related]
18. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains.
Lindenboim L; Borner C; Stein R
Cell Death Differ; 2001 Sep; 8(9):933-42. PubMed ID: 11526448
[TBL] [Abstract][Full Text] [Related]
19. Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement.
Clarke DM; Baust JM; Van Buskirk RG; Baust JG
Cryobiology; 2004 Aug; 49(1):45-61. PubMed ID: 15265716
[TBL] [Abstract][Full Text] [Related]
20. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
